Clueless

[anonymous]

How much of a weirdo is TN???? The guy looks like a sea slug took a dump. And his monotone mongoloid slow speech makes me want to blow my ear drums. How is he still here????? He has NO idea about anything.

 

[anonymous]

He is FAR & AWAY under qualified for his position. His whiny voice makes me want scream

 

[anonymous]

Pencil necked geek.

 

[anonymous]

Entire leadership team is in over their heads. SRDs are the worst and EB, what has he done for us. Over rated!

 

[anonymous]

Entire leadership team is in over their heads. SRDs are the worst and EB, what has he done for us. Over rated!

Old school rinse and repeat mindset does not survive in todays environment….

 

[anonymous]

The entire leadership from RP, TN, GK, and all their minions are complete and unadulterated idiots! I hope JFK Jr. has such a massive impact on this industry that everyone of these pathetic POS gets hosed. I will laugh from my beach chair while sipping mai tai’s.

 

[anonymous]

The entire leadership from RP, TN, GK, and all their minions are complete and unadulterated idiots! I hope JFK Jr. has such a massive impact on this industry that everyone of these pathetic POS gets hosed. I will laugh from my beach chair while sipping mai tai’s.

JFK Jr……having impact on anyone, ever

 

[anonymous]

Just keep taking your paycheck Ginger

 

[anonymous]

He is FAR & AWAY under qualified for his position. His whiny voice makes me want scream

I heard by several reliable sources that they are letting Todd go after the first of the year. He has not hit the numbers that they expected for Aristada. It’s about time they got somebody new in there. That actually wasn’t such an idiot.

 

[anonymous]

Is that why the stock is up?

Will they say that they have changed the leadership in an excuse to give keep the stock up until a narcolepsy drug comes?

Getting rid of TN will not help Vivitrol going generic, Aristada needle clogs losing to Maintena, or Lybalvi not being the hit that was hoped for.

The loss of all of Alks sales tenure was unfortunate and will have effects that they may pin on TN. But not blaming the SRDs is the real mistake. That is who drove ALKS into the ground.

 

[anonymous]

Is that why the stock is up?

Will they say that they have changed the leadership in an excuse to give keep the stock up until a narcolepsy drug comes?

Getting rid of TN will not help Vivitrol going generic, Aristada needle clogs losing to Maintena, or Lybalvi not being the hit that was hoped for.

The loss of all of Alks sales tenure was unfortunate and will have effects that they may pin on TN. But not blaming the SRDs is the real mistake. That is who drove ALKS into the ground.

Nostradamus Prophecy calls for a 2025 exodus of addiction TBMs….clocks ticking with no plans in place.

 

[anonymous]

When every Vivitrol TBM realizes that there will be no retention bonuses offered there will be a mass exodus.